Armata Pharmaceuticals Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARMP American 2836 https://www.armatapharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Armata Pharmaceuticals Inc

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update - Mar 21st, 2024 8:05 pm
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva - Mar 4th, 2024 9:01 pm
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit - Feb 21st, 2024 12:00 pm
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update - Nov 14th, 2023 9:00 pm
Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference - Oct 30th, 2023 12:00 pm
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023 - Oct 19th, 2023 12:00 pm
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus - Sep 26th, 2023 12:00 pm
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference - Sep 21st, 2023 11:00 am
Armata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy? - Aug 17th, 2023 1:55 pm
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update - Aug 14th, 2023 11:00 am
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics - Jul 11th, 2023 12:00 pm
Armata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapy - May 31st, 2023 12:00 pm
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update - May 11th, 2023 8:05 pm